Bioness Inc., headquartered in Valencia, Calif announced that it recently received 510(K) clearance from the U.S. Food and Drug Administration (FDA) and the CE Mark approval by the European Union for its NESS H20 Wireless Rehabilitation System. The NESS H20 Wirelss is designed to improve hand function using mild Functional Electrical Stimulation (FES).  The wireless device promotes motor recovery in patients that have lost upper extremity function after suffering stroke, traumatic brain injury, or spinal cord injury. It also enables individuals with hand paralysis to remain active while integrating essential therapy and training into their daily lives.

Todd Cushman, senior vice-president of Global Business Development and Marketing for Bioness, reiterates this point. In rehabilitation, frequency of therapy and training has direct impact on outcomes, he says, and the more patients can be active and integrate therapy into their day-to-day lives, the better their outcomes.

The NESS H20 Wireless Rehabilitation System is compromised of a wireless, lightweight functional stimulation support, wireless handheld control unit that communicates wirelessly with the system and a clinician’s programmer that provides the ability to program and track patient activity. The device can be utilized in a home or therapy setting.

Source: Bioness Inc.